← All companies

RLYB

Rallybio Corporation

RLYB Nasdaq Pharmaceutical Preparations EDGAR ↗

$15.96

+0.01 +0.06%

Key statistics

from XBRL data in SEC filings

Market cap

$84.6M

Revenue (TTM)

$858K

Net income (TTM)

-$7.82M

EPS (TTM)

$-1.36

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$41.3M

Total assets

$54.5M

Gross margin

—

52-week range

$3.20 – $17.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Terminated a material agreement May 4, 2026 8-K Director or officer change Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Mar 2, 2026 8-K Amended charter or bylaws; Shareholder vote results Jan 29, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Delisting notice or listing-rule failure Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Other events Jul 8, 2025 8-K Director or officer change Jun 27, 2025 8-K Shareholder vote results May 16, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Other events Apr 8, 2025 8-K Other events Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Delisting notice or listing-rule failure Feb 25, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change Jul 23, 2024 8-K Shareholder vote results May 21, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 10, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Results of operations (earnings release); Exit or disposal costs Feb 6, 2024 8-K Regulation FD disclosure Dec 20, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023